Influence of apple polyphenols on inflammatory gene expression

Molecular Nutrition and Food Research

Volumn 53, Issue 10, 2009, Pages 1263-1280

  Jung, Mathias ^a   Triebel, Sven ^a   Anke, Timm ^a   Richling, Elke ^a   Erkel, Gerhard ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Apple polyphenols; Inflammatory gene expression; Phloretin; Procyanidins; Proinflammatory cytokines and chemokines

Indexed keywords

BIFLAVONOID; CATECHIN; CYTOKINE; FLAVONOID; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOL DERIVATIVE; PHLORETIN; PLANT EXTRACT; POLYPHENOLS; PROANTHOCYANIDIN; PROCYANIDIN B1; PROCYANIDIN B2;

APPLE; ARTICLE; CHEMISTRY; DNA MICROARRAY; DRUG EFFECT; FRUIT; GENE EXPRESSION; GENETICS; HUMAN; IC 50; INFLAMMATION; LEUKEMIA CELL LINE; METABOLISM; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIFLAVONOIDS; CATECHIN; CELL LINE, TUMOR; CYTOKINES; FLAVONOIDS; FRUIT; GENE EXPRESSION; GENES, REPORTER; HUMANS; INFLAMMATION; INHIBITORY CONCENTRATION 50; JURKAT CELLS; MALUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOLS; PHLORETIN; PLANT EXTRACTS; PROANTHOCYANIDINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MALUS; MALUS X DOMESTICA; ROSACEAE;

EID: 70350026412     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800575     Document Type: Article

References (86)

1. Scalbert, A., Manach, C., Morand, C., Rémésy, C., Jiménez, L., Dietary polyphenols and the prevention of diseases, Crit. Rev. Food Sci. Nutr. 2005, 45, 287-306.
2. Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols, J. Nutr. 2000, 130, 2073S-2085S.
3. Thielen, C., Will, F., Zacharlas, J., Dietrich, H., Jacob, H., Polyphenols in apples: Distribution of polyphenols in apple tissue and comparison of fruit and juice, Deutsche Lebensmittel-Rundschau 2004, 100, 389-398.
4. Lata, B., Tomala, K., Apple peel as a contributor to whole fruit quantity of potentially healthful bioactive compounds. Cultivar and year implication, J. Agric. Food Chem. 2007, 55, 10795-10802.
5. Vrhovsek, U., Rigo, A., Tonon, D., Mattivi, F., Quantitation of polyphenols in different apple varieties, J. Agric. Food Chem. 2004,52,6532-6538.
6. Manach, C., Scalbert, A., Morand, C., Rémésy C., Jimenéz, L., Polyphenols: Food source and bioavailability, Am. J. Clin. Nutr. 2004, 79, 727-747.
7. Kahle, K., Kraus, M., Richling, E., Polyphenol profiles of apple juices, Mol. Nutr. Food Res. 2005, 49, 797-806.
8. Alonso-Salces, R.-M., Ndjoko, K., Queiroz, E.-F., Ioset, J.-R. et al., On-line characterization of apple polyphenols by liquid chromatography coupled with mass spectrometry and ultraviolet absorbance detection, J. Chromatogr., A 2004, 1046, 89-100.
9. Tsao, R., Yang, R., Young, J.-C., Zhu, H., Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography (HPLC), J. Agric. Food Chem. 2003, 51, 6347-6353.
10. Boyer, J., Liu, R.-H., Apple phytochemicals and their health benefits, Nutr. J. 2004, 3, 5.
11. Gerh user, C., Cancer chemopreventive potential of apples, apple juice, and apple components, Planta Med. 2008, 74, 1608-1624.
12. Santangelo, C., Var, R., Scazzocchio, B., Di Benedetto, R., Filesi, C., et al., Polyphenols, intracellular signalling and inflammation, Ann. Ist. Super Sanit. 2007, 43, 394-405.
13. Hong, J., Smith, J., Ho, C.-T., August, D.-A., Yang, S., Effects of purified green and black tea polyphenols on cyclooxygenase and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues, Biochem. Pharmacol. 2001, 62, 1175-1183.
14. Kundu, J.-K., Na, H.-K., Chun, K.-S., Kim, Y.-K., et al., Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells, J. Nutr. 2003, 133, 3805-3810.
15. Seeram, N.-P., Zhang, Y., Nair, M.-G., Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins, Nutr. Cancer 2003, 46, 101-106.
16. Gerh user, C., Klimo, K., Heiss, E., Neumann, I., et al., Mechanism-based in vitro screening of potential cancer chemopreventive agents, Mutat. Res., Fundam. Mol. Mech. Mutagen. 2003, 523-524, 163-172.
17. Lyu, S.-Y., Park, W.-B., Production of cytokines and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids, Arch. Pharmacal Res. 2005, 28, 573-581.
18. Visioli, F., Galli, C., The effect of minor constituents of olive oil on cardiovascular disease: New findings, Nutr. Rev. 1998, 56,142-147.
19. Yamamoto, Y., Gaynor, R.-B., IkappaB kinases: Key regulators of the NF-kappaB pathway, Trends Biochem. Sci. 2004, 29,72-79.
20. Rahman, I., Biswas, S.-K., Kirkham, P.-A., Regulation of infammation and redox signaling by dietary polyphenols, Biochem. Pharmacol. 2006, 72, 1439-1452.
21. Rahman, I., Marwick, J., Kirkham, P., Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-kappaB and pro-infammatory gene expression, Biochem. Pharmacol. 2004, 68, 1255-1267.
22. Wheeler, D.-S., Catravas, J.-D., Odoms, K., Denenberg, A., et al., Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinfammatory signal transduction in cultured respiratory epithelial cells, J. Nutr. 2004,134,1039-1044.
23. Aneja, R., Hake, P.-W., Burroughs, T.-J., Denenberg, A.-G., et al., Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats, Mol. Med. 2004, 10,55-62.
24. Ruiz, P.-A., Braune, A., Holzlwimmer, G., Quintanilla-Fend, L., et al., Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to pro-infammatory gene promoters in murine intestinal epithelial cells, J. Nutr. 2007, 137, 1208-1215.
25. Bouma, G., Strober, W., The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003, 3, 521-533.
26. Will, F., Bauckhage, K., Dietrich, H., Apple pomace liquefaction with pectinases and cellulases: Analytical data of the corresponding juices, Eur. Food Res. Technol. 2000, 211, 291-297.
27. O'Brien, J., Wilson, I., Orton, T., Pognan, F., Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, Eur. J. Biochem. 2000, 267,5421-5426.
28. Roehm, N.-W., Rodgers, H., Hatfield, S.-M., Glasebrook, A. L., An improved colometric assay for cell proliferation and viability utilising the tetrazolium salt XTT, J. Immunol. Methods 1991, 142, 257-265.
29. Pfaffl, M.-W., A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acid Res. 2001, 29, 2002-2007.
30. Spurrell, J., Wiehler, S., Zaheer, R.-S., Sanders, S.-P. et al., Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection, Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289, 85-95.
31. Erkel, G., Wisser, G., Anke, T., Influence of the fungal NF-jB inhibitor panepoxydone on inflammatory gene expression in MonoMac6 cells, Int. Immunopharmacol. 2007, 7, 612-624.
32. Will, F., Bauckhage, K., Dietrich, H., Apple pomace liquefaction with pectinases and cellulases: Analytical data of the corresponding juices, Eur. Food Res. Technol. 2000, 211, 291-297.
33. Schaefer, S., Baum, M., Eisenbrand, G., Dietrich, H., et al., Polyphenolic apple juice extracts and their major constituents reduce oxidative damage in human colon cell lines, Mol. Nutr. Food Res. 2006, 50, 24-33.
34. Huemmer, W., Dietrich, H., Will, F., Schreier, P., Richling, E., Content and mean polymerization degree of procyanidins in extracts obtained from clear and cloudy apple juices, Biotechnol. J. 2008, 3, 234-243.
35. Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., Kracht, M., Multiple control of Interleukin 8 gene expression, J. Leukoc. Biol. 2002, 72, 847-855.
36. Marx, N., Mach, F., Sauty, A., Leung, J.-H., et al., Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells, J. Immunol. 2000, 164, 6503-6508.
37. Boorsma, D.-M., Flier, J., Sampat, S., Ottevanger, C., et al., Chemokine IP-10 expression in cultured human keratinocytes, Arch. Dermatol. Res. 1998, 290, 335-341.
38. Dajotoy, T., Andersson, P., Bjartell, A., Lofdahl, C.-G., et al., Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma, J. Leukoc. Biol. 2004, 76, 685-691.
39. Gasperini, S., Marchi, M., Calzetti, F., Laudanna, C., et al., Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils, J. Immunol. 1999, 162, 4928-4937.
40. Dwinell, M.-B., Lugering, N., Eckmann, L., Kagnoff, M.-F., Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells, Gastroenterology 2001, 120, 49-59.
41. Saetta, M., Mariani, M., Panina-Bordignon, P., Turato, G., et al., Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 2002, 165, 1404-1409.
42. Miotto, D., Christodoulopoulos, P., Olivenstein, R., Taha, R., et al., Expression of IFN-c-inducible protein, monocyte chemotactic proteins1, 3, and 4, and eotaxin in TH1-and TH2-mediated lung diseases, J. Allergy Clin. Immunol. 2001, 107, 664-670.
43. Yeruva, S., Ramadori, G., Raddatz, D., NF-jB-dependent synergistic regulation of CXCL10 gene expression by IL-1b and IFN-c in human intestinal epithelial cell lines, Int. J. Colorectal Dis. 2008, 23, 305-317.
44. Banks, C., Bateman, A., Payne, R., Johnson, P., Sheron, N., Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and crohn's disease, J. Pathol. 2003, 199, 28-35.
45. Uguccioni, M., Gionchetti, P., Robbiani, D.-F., Rizzello, F., et al., Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis, Am. J. Pathol. 1999, 155, 331-336.
46. Sierro, F., Dubois, B., Coste, A., Kaiserlian, D. et al., Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells, Proc. Natl. Acad. Sci. USA 2001, 98, 13722-13727.
47. Brand, S., Sakaguchi, T., Gu, X., Colgan, S.-P., Reinecker, H.-C., Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells, Gastroenterology 2002, 122, 166-177.
48. Majumder, S., Zhou, L., Chaturvedi, P., Babcock, G., et al., p48/stat-1a-containing complexes play a predominant role in induction of IFN-inducible protein 10 kda (IP 10) by IFN alone or in synergy with TNF-a, J. Immunol. 1998, 98, 4736-4744.
49. Czech, W., Krutmann, J., Budnik, A., Schopf, E., Kapp, A., Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines, J. Invest. Dermatol. 1993, 100, 417-423.
50. Lee, A.-H., Hong, J.-H., Seo, Y.-S., Tumour necrosis factoralpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors, Biochem. 2000, 350, 131-138.
51. Ohmori, Y., Schreiber, R.-D., Hamilton, T.-A., Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappa B, J. Biol. Chem. 1997, 272, 14899-14907.
52. Pine, R., Convergence of TNF-a and IFN-c signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element, Nucleic Acids Res. 1997, 25, 4346-4354.
53. Karin, M., Greten, F.-R., NF-jB: Linking inflammation and immunity to cancer development and progression, Nat. Rev. Immunol. 2005, 5, 749-759.
54. Rao, A., Luo, C., Hogan, P.-G., Transcription factors of the NF-AT family: Regulation and function, Annu. Rev. Immunol. 1997,15,707-747.
55. Serfling, E., Berberich-Siebelt, F., Avots, A., Chuvpilo, S., et al., NF-AT and NF-jB factors the distant relatives. Int. J. Biochem. Cell Biol. 2004, 36, 1166-1170.
56. Tracey, K.-J., Cerami, A., Tumor Necrosis Factor: A pleiotropic cytokine and therapeutic target, Annu. Rev. Med. 1993, 9,317-343.
57. Johnson, D.-R., Pober, J.-S., HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons, Mol. Cell. Biol. 1994, 14, 1322-1332.
58. Barker, J., Sarma, V., Mitra, R.-S., Dixit, V.-M., Nickoloff, B.-J., Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors, J. Clin. Invest. 1990,85,605-608.
59. Doyle, S.-L., O'Neill, L.-A., Toll-like receptors: From the discovery of NF-kB to new insights into transcriptional regulations in innate immunity, Biochem. Pharmacol. 2006, 72, 1102-1113.
60. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., Akira, S., Unresponsiveness of MyD88-decient mice to endotoxin, Immunity 1999, 11, 115-122.
61. Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., et al., Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4, Nature 2002, 420, 324-329.
62. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., et al., Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling, J. Immunol. 2002, 169, 6668-6672.
63. Yang, F., Oz, H.-S., Barve, S., Villiers, W.-J. et al., The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting Ikappa B kinase activity in the intestinal epithelial cell line IEC-6, Mol. Pharmacol. 2001, 60, 528-533.
64. Mackenzie, G., Adamo, A.-M., Decker, N.-P., Oteiza, P.-I., Dimeric procyanidin B2 inhibits constitutively active NF-jB in Hodgkin's lymphoma cells independently of the presence of IjB mutations, Biochem. Pharmacol. 2008, 75, 1461-1471.
65. Tedeschi, E., Menegazzi, M., Yao, Y., Suzuki, H., et al., Green tea inhibits human inducible nitric oxidase expression by down-regulation signal transducer and activator of transcription-1alpha activation, Mol. Pharmacol. 2004, 65, 111-120.
66. Subramanian, S., Rhodes, J.-M., Hart, C.-A., Tam, B., et al., Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine, Inflamm. Bowel Dis. 2008, 14, 162-175.
67. Hipp, M.-S., Urbich, C., Mayer, P., Wischhusen, J., et al., Proteasome inhibition leads to NF-jB-independent IL-8 transactivation in human endothelial cells through induction of AP-1, Eur. J. Immunol. 2002, 32, 2208-2217.
68. Eferl, R., Wagner, E.-F., AP-1: A double-edged sword in tumorigenesis, Nat. Rev. Cancer 2003, 3, 859-868.
69. Shen, F., Chen, S.-J., Dong, X.-J., Zhong, H., et al., Suppression of IL-8 gene transduction by resveratrol in phorbol ester treated human monocytic cells, J. Asian Nat. Prod. Res. 2003, 5,151-157.
70. Swantek, J.-L., Christerson, L., Cobb, M.-H., Lipopolysaccharide-induced tumor necrosis factor-a promoter activity is inhibitor of nuclear factor-jB kinase dependent, J. Biol. Chem. 1999, 274, 11667-11671.
71. Habtemariam, S., Natural inhibitors of tumor necrosis factora production, secretion and function, Planta Med. 2000, 4, 303-13.
72. Andoh, A., Yagi, Y., Shioya, M., Nishida, A., et al., Mucosal cytokine network in inflammatory bowel disease, World J. Gastroenterol. 2008, 14, 5154-5161.
73. Segal, P.-B., Regulation of IL 6 gene expression, Res. Immunol. 1992, 143, 724-734.
74. Ludwiczek, O., Vannier, E., Borggraefe, I., Kaser, A., et al., Imbalance between interleukin-1 agonists and antagonists: Relationship to severity of inflammatory bowel disease, Clin. Exp. Immunol. 2004, 138, 323-329.
75. Okahara, S., Arimura, Y., Yabana, T., Kobayashi, K., et al., Inflammatory gene signature in ulcerative colitis with cDNA microarray analysis, Aliment. Pharmacol. Ther. 2005, 21, 1091-1097.
76. Gouwy, M., Struyf, S., Proost, P., Van Damme, J., Synergy in cytokine and chemokine networks amplifies the inflammatory response, Cytokine Growth Factor Rev. 2005, 16, 561-580.
77. Kracht, M., Saklatvala, J., Transcriptional and post-transcriptional control of gene expression in inflammation, Cytokine 2002,20,91-106.
78. Kmiec, Z., Cytokines in inflammatory bowel disease, Arch. Immunol. Ther. Exp. 1998, 46, 143-155.
79. Shapiro, V.-S., Mollenauer, M.-N., Greene, W.-C., Weiss, A., C-rel regulation of IL-2 gene expression may be mediated through activation of AP-1, J. Exp. Med. 1996, 184, 1663-1669.
80. Cox, D.-G., Crusius, J.-B., Peeters, P.-H., Bueno-de-Mesquita, H.-B., et al., Haplotype of prostaglandin synthase 2/ cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease, World J. Gastroenterol. 2005, 11, 6003-6008.
81. Surth, Y.-J., Chun, K.-S., Cha, H., Han, S., et al., Molecular mechanisms underlying chemopreventive activities of antiinflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-jB activation, Mutat. Res. 2001, 480-481, 243-268.
82. Zhang, W., Liu, H., Xie, K., Yin, L., et al., Procyanidin dimer B2 [epicatechin-(4b-8)-epicatechin] suppresses the expression of cyclooxygenase-2 in endotoxin-treated monocytic cells, Biochem. Biophys. Res. Commun. 2006, 345, 508-515.
83. Heller, R.-A., Schena, M., Chai, A., Shalon, D., et al., Discovery and analysis of inflammatory disease related genes using cDNA microarrays, Proc. Natl. Acad. Sci. USA 1997, 94, 2150-2155.
84. Harant, H., Eldershaw, S.-H., Lindley, I., Human macrophage inflammatory protein-3a/ CCL20/ LARC/ Exodus/ SCYA20 is transcriptionally upregulated by tumor necrosis factor-a via non-standard NF-jB site, FEBS Lett. 2001, 509, 439-445.
85. Goggins, M.-G., Goh, J., O'Connell, M.-A., Weir, D.-G., et al., Soluble adhesion molecules in inflammatory bowel disease, Ir. J. Med. Sci. 2001, 170, 107-111.
86. Stangl, V., Lorenz, M., Ludwig, A., Grimbo, N., et al., The Flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets, J. Nutr. 2005, 135, 172-178.